Valuation: Allied Corp.

Market Cap 1.3M 1.15M 1.06M 986K 1.85M 123M 1.88M 12.66M 4.9M 60.64M 4.9M 4.79M 211M P/E 2023
-2.13x
P/E 2024 -2.52x
Enterprise Value 7.55M 6.63M 6.11M 5.71M 10.72M 713M 10.91M 73.32M 28.4M 351M 28.36M 27.74M 1.22B EV / Sales 2023
394,366,816x
EV / Sales 2024 171,944,593x
Free-Float
52.84%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer 71 -
Corporate Officer/Principal - 2020-05-01
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 2020-05-01
Director/Board Member - 2024-10-20
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-5.00% - - 117
+2.95%-4.15%+298.54%+10.81% 2.46B
+0.24%-15.64%+134.07%+115.70% 1.63B
-1.26%-10.27%-14.79%+128.62% 462M
-4.00%-2.04%+17.07%-20.00% 53.64M
Average -1.41%-5.08%+108.72%+58.78% 1.15B
Weighted average by Cap. +1.49%-7.22%+205.52%+59.47%

Financials

2023 2024
Net sales 0.07 0.06 0.06 0.05 0.1 6.8 0.1 0.7 0.27 3.35 0.27 0.26 11.65 0.1 0.08 0.08 0.07 0.14 9.08 0.14 0.93 0.36 4.47 0.36 0.35 15.55
Net income -10.68M -9.38M -8.64M -8.08M -15.15M -1.01B -15.43M -104M -40.15M -497M -40.09M -39.21M -1.73B -3.98M -3.49M -3.22M -3.01M -5.64M -375M -5.75M -38.61M -14.95M -185M -14.93M -14.6M -643M
Net Debt 5.65M 4.96M 4.57M 4.28M 8.02M 533M 8.17M 54.88M 21.26M 263M 21.22M 20.76M 914M 6.25M 5.49M 5.06M 4.73M 8.87M 590M 9.03M 60.66M 23.5M 291M 23.46M 22.95M 1.01B
Logo Allied Corp.
Allied Corp. is an international medical cannabis production company. The Company is engaged in researching, creating, and producing targeted cannabinoid health solutions. It focuses on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder (PTSD), Parkinson’s disease, Tourette’s syndrome, irritable bowel syndrome (IBS) and spasticity associated with multiple sclerosis (MS) and spinal cord injury (SCI). Its core hemp-derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. The Tactical Relief brand's flagship product is a hemp-derived CBD tincture for sale in the United States. The Equilibrium Bio brand is primarily focused on hydration and recovery areas. The MaXXa brand develops natural CBD-infused cosmetics and beauty products.
Employees
-